Pulmonary vein stenosis: prematurity and associated conditions. (33/87)

 (+info)

Pulmonary veno-occlusive disease: diagnostic and therapeutic alternatives. (34/87)

 (+info)

Pulmonary veno-occlusive disease. (35/87)

 (+info)

Pulmonary veno-occlusive disease in myeloproliferative disorder. (36/87)

 (+info)

Complications in the catheter ablation of atrial fibrillation: incidence and management. (37/87)

Radiofrequency catheter ablation is widely performed as an effective treatment for recurrent, drug-resistant atrial fibrillation (AF). Recently, various types of ablation strategies, such as extensive encircling pulmonary vein (PV) isolation, linear ablation and complex fractionated electrogram-guided ablation, have been used to achieve a high efficacy for all types of AF. However, several complications (thromboembolic events, PV stenosis and atrio-esophageal fistula etc) with an incidence of 3.9-6%, have been reported. It is important to understand the incidence, prevention and management of complications in order to develop safe ablation strategies.  (+info)

Development of novel drug-eluting biodegradable nano-fiber for prevention of postoperative pulmonary venous obstruction. (38/87)

 (+info)

Granulomatous angiitis leading to a pulmonary veno-occlusive disease-like picture. (39/87)

 (+info)

Pulmonary arterial hypertension in limited cutaneous systemic sclerosis: a distinctive vasculopathy. (40/87)

 (+info)